3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
8
Withdrawn
1
Unknown
1
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
25
Burkitt Lymphoma
13
Leukemia, Biphenotypic, Acute
9
Leukemia, Myeloid, Acute
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Osteosarcoma
3
Myelodysplastic Syndromes
3
Lymphoma
3
Breast Neoplasms
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Primary Myelofibrosis
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Non-Hodgkin
2
Leukemia, Large Granular Lymphocytic
2
Leukemia
2
Hematologic Neoplasms
2
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Sarcoma, Ewing
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Recurrence
1
Polycythemia Vera
1
Pathologic Complete Response
1
Oropharyngeal Neoplasms
1
Neoplasm, Residual
1
Myelodysplastic-Myeloproliferative Diseases
1
Mouth Neoplasms
1
Interventions
ruxolitinib
4
Specimen Handling
2
Hydroxyurea
2
Biopsy
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
talazoparib
1
piperine
1
givinostat hydrochloride
1
givinostat
1
fludarabine phosphate
1
fludarabine
1
fedratinib
1
demethoxycurcumin
1
bomedemstat
1
X-Rays
1
Whole-Body Irradiation
1
Watchful Waiting
1
Tacrolimus
1
Stem Cell Transplantation
1
Positron-Emission Tomography
1
N(4)-oleylcytosine arabinoside
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Interferons
1
Interferon-alpha
1
Injections
1
Hematopoietic Stem Cell Transplantation
1
Decitabine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Polycythemia Vera
×
Methotrexate
×
Clear all
NCT06541249
2025-12-17
TREATMORE
Icahn School of Medicine at Mount Sinai
Phase 2
Recruiting
54 enrolled